These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36421696)

  • 21. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans.
    Ouyang XY; Qiao J
    Chin Med J (Engl); 2006 Sep; 119(18):1511-21. PubMed ID: 16996004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous platelet concentrates for treating periodontal infrabony defects.
    Del Fabbro M; Karanxha L; Panda S; Bucchi C; Nadathur Doraiswamy J; Sankari M; Ramamoorthi S; Varghese S; Taschieri S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011423. PubMed ID: 30484284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
    Kitamura M; Akamatsu M; Kawanami M; Furuichi Y; Fujii T; Mori M; Kunimatsu K; Shimauchi H; Ogata Y; Yamamoto M; Nakagawa T; Sato S; Ito K; Ogasawara T; Izumi Y; Gomi K; Yamazaki K; Yoshie H; Fukuda M; Noguchi T; Takashiba S; Kurihara H; Nagata T; Hamachi T; Maeda K; Yokota M; Sakagami R; Hara Y; Noguchi K; Furuuchi T; Sasano T; Imai E; Ohmae M; Koizumi H; Watanuki M; Murakami S
    J Bone Miner Res; 2016 Apr; 31(4):806-14. PubMed ID: 26547659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report.
    Stavropoulos A; Karring T
    Clin Oral Investig; 2005 Dec; 9(4):271-7. PubMed ID: 16010581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor (rhFGF) -2 for Stage III Grade C Periodontitis: A Case Report with 6-month Follow-up.
    Saito Y; Imamura K; Seshima F; Nakazaki T; Tomita S; Saito A
    Bull Tokyo Dent Coll; 2023 Dec; 64(4):135-144. PubMed ID: 37967937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of adjunctive procedures on recombinant human fibroblast growth factor-2-mediated periodontal regeneration therapy: A retrospective study.
    Nakayama Y; Matsuda H; Itoh S; Iwai Y; Takai H; Mezawa M; Yoshino S; Ogata Y
    J Periodontol; 2021 Jul; 92(7):983-994. PubMed ID: 33128399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enamel matrix derivative for the treatment of partially contained intrabony defects: 12-month results.
    Corbella S; Alberti A; Calciolari E; Taschieri S; Francetti L
    Aust Dent J; 2019 Mar; 64(1):27-34. PubMed ID: 30257036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amnion membrane as a novel barrier in the treatment of intrabony defects: a controlled clinical trial.
    Kiany F; Moloudi F
    Int J Oral Maxillofac Implants; 2015; 30(3):639-47. PubMed ID: 26009915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIOACTIVE GLASS-CERAMIC COMPOSITION IN SURGICAL MANAGEMENT OF PERIODONTAL INTRABONY DEFECTS.
    Lysenko O; Borysenko A
    Georgian Med News; 2019 Oct; (295):34-41. PubMed ID: 31804196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deproteinized bovine bone and gentamicin as an adjunct to GTR in the treatment of intrabony defects: a randomized controlled clinical study.
    Stavropoulos A; Karring ES; Kostopoulos L; Karring T
    J Clin Periodontol; 2003 Jun; 30(6):486-95. PubMed ID: 12795786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term stability of adjunctive use of enamel matrix protein derivative on porcine-derived xenograft for the treatment of one-wall intrabony defects: A 4-year extended follow-up of a randomized controlled trial.
    Lee JH; Jeong SN
    J Periodontol; 2022 Feb; 93(2):229-236. PubMed ID: 34050681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of periodontal intrabony defects using bovine porous bone mineral and guided tissue regeneration with/without platelet-rich fibrin: A randomized controlled clinical trial.
    Liu K; Huang Z; Chen Z; Han B; Ouyang X
    J Periodontol; 2021 Nov; 92(11):1546-1553. PubMed ID: 33569807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: randomized controlled clinical trial.
    Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mamajiwala BS
    Clin Oral Investig; 2021 Sep; 25(9):5257-5271. PubMed ID: 33598778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Amore C; Montebugnoli L; De Sanctis M
    J Periodontol; 2003 Dec; 74(12):1725-35. PubMed ID: 14974812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.